Given the limited number of clinical trials undertaken in PHTS to date, PTEN Research understands the value of case studies outlining treatment of various aspects of PHTS and, therefore, maintains a tracker of case studies reported in the literature of PHTS patients treated with rapalogs and other PI3K pathway inhibitors more generally.
A summary of the studies we have recorded can be requested from research@ptenresearch.org, noting it is not based on a systematic literature search.